The Deal
Tuesday, November 24, 
5:29 am

The Deal's Healthcare Dealmaking Symposium: Healthcare Technology

  Share     E-Mail    Discussion    Print Story

Healthcare technology is an everchanging facet of the sector where deals are happening, but the atmosphere for deals has been hampered by the niche technology.

Continue reading below

Also on Dealscape

Panelists Charles J. Ditkoff, managing director of the global healthcare group at Bank of America Securities Group LLC, and Ezra Perlman, partner at Francisco Partners LP, joined moderator George Hill, vice president of investment banking at Leerink Swann, to discuss dealmaking in the healthcare technology sector. Ditkoff said the customer base within the sector is so diverse it's difficult to consolidate. Perlman concurred, also pointing out, specifically, to the "personality- driven CEOs" who own smaller tech niche companies that don't necessarily want to sell.

The heathcare technology sector seems somewhat fragmented between big players such as General Electric Co. or McKesson Corp. and smaller "mom and pops" shops. It also doesn't help dealmaking when companies create niche healthcare software that is suited for just one hospital not necessarily for a whole system, which makes selling the company very difficult.

As far as going public for these healthcare technology companies, the two panelists said there is a great appetite for healthcare technology companies from investors.

But the reality is, according to Ditkoff, that there's "a big disconnect between the industry and the whole macro level. Some companies have great products ... but if they try to do more [than they're capable of] they'll stumble." And that doesn't translate well for public companies. - Gerald Magpily





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Morgan Stanley's Rosenthal on the nitty gritty details of the Smith Barney integration.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Loan-to-buy

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.